Dr Michelle Hill received a PhD in cell biology from the University of Queensland (UQ), Brisbane, Australia. Following post-doctoral work at Friedrich Miescher Institute for Biomedical Research, Trinity College Dublin, and the Institute for Molecular Biosciences UQ, Dr Hill established the cancer proteomics group at UQ Diamantina Institute. Current major focus is on the role of caveolin and lipid rafts in cancer progression and cancer biomarker discovery using lectin magnetic bead array. She is an organizing member of Australasian Proteomics Society and Queensland Proteomics Discussion Group and serves on the editorial boards of international proteomics and cell biology journals.   Dr Michelle Hill received a PhD in cell biology from the University of Queensland (UQ), Brisbane, Australia. Following post-doctoral work at Friedrich Miescher Institute for Biomedical Research, Trinity College Dublin, and the Institute for Molecular Biosciences UQ, Dr Hill established the cancer proteomics group at UQ Diamantina Institute. Current major focus is on the role of caveolin and lipid rafts in cancer progression and cancer biomarker discovery using lectin magnetic bead array. She is an organizing member of Australasian Proteomics Society and Queensland Proteomics Discussion Group and serves on the editorial boards of international proteomics and cell biology journals.

cancer biomarker